UK & European patent attorney
MA (Cantab), PhD, EPA, CPA
Juliet is a partner in Mathys & Squire’s life sciences team, working in the fields of molecular biology, pharmaceuticals and biotechnology. She has a first class master’s degree in Natural Sciences, specialising in genetics, from the University of Cambridge and has a PhD in molecular genetics from the same university. Juliet entered the patent profession in 2011.
Expertise
Juliet is experienced in examination and opposition proceedings at the European Patent Office, as well as drafting, prosecution and management of global patent portfolios. She also advises clients on infringement, validity and freedom-to-operate matters. Juliet works in the fields of molecular biology, pharmaceuticals and biotechnology, and has particular experience in the areas of antibody technology, vaccine technology, protein and peptide based medicines, personalised medicine, recombinant gene expression and diagnostic assays.
Academic
Juliet graduated from the University of Cambridge with a first class honours degree in Natural Sciences, specialising in genetics. She went on to obtain a PhD in molecular genetics from the same university. During her PhD, Juliet studied the role of nuclear organisation in the regulation of gene expression through the use of immunoassays, fluorescent in situ hybridisation, confocal microscopy, bioinformatics and traditional genetics techniques.
Memberships & organisations
Juliet is a fellow of the Chartered Institute of Patent Attorneys and is a member of the European Patent Institute.
Sectors
Biotechnology
Life sciences & chemistry
Pharmaceuticals
“Mathys & Squire has consistently provided excellent, thorough and proactive strategic legal counsel to our company on very complex matters. The firm’s stellar reputation is well-deserved. Their lawyers have a firm command of cutting edge substantive law, are very responsive and are a pleasure to work with. I highly recommend them.”
Subscribe to our mailing list to receive our monthly newsletter which includes the latest news and industry insights.
Please select your areas of interest:
This website uses cookies to ensure you get the best experience on our website